首页> 外文期刊>Theriogenology >Influences of treatment of early pregnant mares with the progestin altrenogest on embryonic development and gene expression in the endometrium and conceptus
【24h】

Influences of treatment of early pregnant mares with the progestin altrenogest on embryonic development and gene expression in the endometrium and conceptus

机译:孕激素对孕早期母马的治疗对子宫内膜和子宫内膜胚胎发育和基因表达的影响

获取原文
获取原文并翻译 | 示例
           

摘要

A positive influence of altrenogest treatment on a retarded development of the conceptus around the beginning of placentation in mares older than 8 years could be recently demonstrated. In the present study, effects of altrenogest treatment in early-pregnant mares on conceptus development and expression of endometrial and embryonic genes were investigated. Genes were chosen according to a possible involvement in embryo-maternal interaction and embryonic development in the equine species. Mares were treated with altrenogest (0.044 mg/kg bodyweight) or sunflower oil (placebo) from day 5 to 11 after ovulation. Embryos (altrenogest n = 13, placebo n = 12) and biopsies were collected on day 11. Pregnancy rate and embryonic size were not influenced by treatment (embryonic diameter: altrenogest 7.0 +/- 2.5, placebo 6.5 +/- 1.7 mm, n.s.). The percentage of luminal epithelial cells, superficial glandular epithelial cells and interstitial cells with nuclei staining positively for the progesterone receptor was significantly lower (P < 0.05) in samples collected from altrenogest-treated than from placebo-treated mares (e.g., luminal epithelium: altrenogest 1.9 +/- 1.7%, placebo 23.0 +/- 10.5%,-P < 0.05). Staining for COX2 (cyclooxygenase-2) was not affected by treatment. In the endometrium a slight but significant increase in the number of PMN (polymorph nuclear neutrophils) was seen in response to treatment (altrenogest 0.8 +/- 0.5 PMN/field, placebo 0.3 +/- 0.3 PMN/field; P < 0.05). No differences in the relative gene expression of COX2, the receptors for progesterone, estrogens and growth hormone as well as for IGF (insulin-like growth factor) 1 and 2 were detected. The relative gene expression of aquaporin 3 in relation to beta-actin differed significantly (P < 0.05) between embryos from altrenogest (3.2 +/- 0.8) and placebo-treated mares (1.3 +/- 0.2), but no other genes were affected. The study demonstrates down-regulation of progesterone receptors in the endometrium of early pregnant mares by treatment with the progestin altrenogest. This increased expression of aquaporin 3 in the conceptus was not related to changes in embryonic size or development
机译:最近可以证明,在8岁以上的母马中,在怀孕开始时,altrenogest治疗对胎盘发育迟缓有积极影响。在本研究中,研究了孕早期母体海藻糖治疗对子宫内膜发育和子宫内膜及胚胎基因表达的影响。根据可能参与马种中的胚胎与母体相互作用和胚胎发育来选择基因。从排卵后第5天到第11天,母猪用海藻糖(0.044 mg / kg体重)或葵花籽油(安慰剂)治疗。在第11天收集了胚胎(altrenogest,n = 13,安慰剂,n = 12)和活组织检查。妊娠率和胚胎大小不受治疗的影响(胚胎直径:altrenogest 7.0 +/- 2.5,安慰剂6.5 +/- 1.7 mm,ns )。从孕酮处理过的母猪(例如,腔上皮:altrenogest)收集的样品中,孕酮受体的腔上皮细胞,浅腺上皮细胞和间质细胞中孕酮受体呈阳性染色的百分比显着较低(P <0.05) 1.9 +/- 1.7%,安慰剂23.0 +/- 10.5%,-P <0.05)。 COX2(环氧合酶-2)的染色不受处理的影响。在子宫内膜中,对治疗有反应的PMN(多形核中性粒细胞)数量略有但显着增加(海藻糖0.8 +/- 0.5 PMN /场,安慰剂0.3 +/- 0.3 PMN /场; P <0.05)。没有发现COX2,孕激素,雌激素和生长激素以及IGF(胰岛素样生长因子)1、2的相对基因表达的差异。水通道蛋白3相对于β-肌动蛋白的相对基因表达在altrenogest(3.2 +/- 0.8)和安慰剂处理的母马(1.3 +/- 0.2)的胚胎之间有显着差异(P <0.05),但没有其他基因受到影响。这项研究表明,早期孕母的子宫内膜中的孕激素受体通过下孕激素治疗而下调。水通道蛋白3在概念中的表达增加与胚胎大小或发育的改变无关

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号